Not much else to say.
From the overnight Dr. Noseworthy announcement/press release then:
. . . .“We are pleased to nominate Dr. John Noseworthy to stand for election to the Merck board and look forward to benefiting from his first-hand insights about patient care and health care delivery as a leader of one of the largest non-profit health systems in the United States,” said Kenneth C. Frazier, chairman and chief executive officer, Merck.
Dr. John H. Noseworthy is president and chief executive officer of Mayo Clinic, a not-for-profit organization operating in five states that is dedicated to medical care, research and education. Prior to his current appointment, he served as chair of Mayo Clinic’s Department of Neurology, medical director of the Department of Development, and vice chair of the Mayo Clinic Rochester Executive Board. Dr. Noseworthy is a professor in the Department of Neurology and served as editor-in-chief for Neurology, the official journal of the American Academy of Neurology. . . .
Now you know. I'm sure Dr. Noseworthy will serve honorably -- and keep his word, to be independent. Onward.
नमस्ते
2 comments:
I know you are always up on these things but...in case: http://www.fiercepharma.com/financials/merck-s-frazier-gets-his-first-raise-but-total-compensation-drops-as-sales-stall
cheers
Anon
Thank you so much Anon. --
Actually -- I only barely mentioned his 2016 pay, in the bracketed material in my first paragraph above this morning, because I think. . . . he's earned it (which different than being worth it). So I won't catch any immediate vapors over it -- even if no CEO, globally -- is really worth that kind of money. It is the going rate for first class talent.
Do stop back -- Namaste
Post a Comment